Increasing international travel, migration to and from epidemic areas, and the emergence of epidemic Corynebacterium diphtheriae strains globally have highlighted the need for better microbiologic surveillance and greater clinical and laboratory awareness. As part of the strategy developed by the World Health Organization, one major goal is particularly applicable to the microbiology and epidemiology of diphtheria: to improve surveillance for early detection of emerging and reemerging diseases by establishing a network of national and international laboratories. The European Laboratory Working Group on Diphtheria (ELWGD) was therefore formed in 1993 as a result of the epidemic situation in Eastern Europe. Currently, there is participation from 20 different countries from Western and Eastern Europe, the United States, Australia, and Southeast Asia. ELWGD is a prime example of a collaborative and coordinated approach to the microbiology of diphtheria and should serve as a potential model for other infectious diseases networks.
Increasing international travel, migration to and from epidemic areas, and the emergence of epidemic Corynebacterium diphtheriae strains globally have highlighted the need for better microbiologic surveillance and greater clinical and laboratory awareness. As part of the strategy developed by the World Health Organization, one major goal is particularly applicable to the microbiology and epidemiology of diphtheria: to improve surveillance for early detection of emerging and reemerging diseases by establishing a network of national and international laboratories. The European Laboratory Working Group on Diphtheria (ELWGD) was therefore formed in 1993 as a result of the epidemic situation in Eastern Europe. Currently, there is participation from 20 different countries from Western and Eastern Europe, the United States, Australia, and Southeast Asia. ELWGD is a prime example of a collaborative and coordinated approach to the microbiology of diphtheria and should serve as a potential model for other infectious diseases networks.
As we approach the twenty-first century, diphtheria is still a major cause for Europe-wide and global concern [1, 2] . Imported cases from not only Eastern Europe but also other epidemic areas, such as the Indian subcontinent, Southeast Asia, and South America, are reported annually in many European countries [3] . Increasing international travel, migration to and from Eastern Europe, and the emergence of epidemic strains of the causative organism, Corynebacterium diphtheriae, highlight the need for better microbiologic surveillance and greater clinical and laboratory awareness [3] .
As part of the World Health Organization (WHO)/UNICEF strategy for diphtheria control in the Newly independent States (NIS), one issue is particularly applicable to the laboratory surveillance of diphtheria: Adequate means for laboratory confirmation of diphtheria is an essential component of surveillance and, therefore, for epidemic control measures. It is crucial to ensure the availability of specialized culture media and other reagents necessary for basic microbiologic diagnosis and identification of C. diphtheriae so as to improve surveillance for early detection of cases and contacts. This can only be effectively achieved with accurate microbiologic surveillance and the establishment of a network of national and international laboratories within the European Region and beyond [1, 4] . These Reprints or correspondence: Dr. Androulla Efstratiou, WHO Collaborating Center for Diphtheria and Streptococcal Infections, PHLS Respiratory and Systemic Infection Laboratory, Central Public Health Laboratory, 61 Colindale Ave., London NW9 5HT, United Kingdom (aefstratiou @phls.nhs.uk). points emphasize the importance of microbiologic networks and continuous international collaboration for both laboratory diagnosis and microbiologic surveillance of this reemergent disease, and, hence, the establishment of the European Laboratory Working Group on Diphtheria (ELWGD).
Formation and Objectives of ELWGD
ELWGD was formed at the initiative of the WHO European Office in July 1993 as a result of the epidemic situation in Eastern Europe. The first meeting on the "Diphtheria Epidemic in Europe, Emergency and Response," which was organized by Fondation Mérieux in collaboration with the WHO Regional Office for Europe, was convened in St. Petersburg in July 1993 in view of the urgent need for action to combat the epidemic in the Russian Federation and Ukraine and its dissemination to other countries [5] . The meeting provided an excellent opportunity for group discussion by key scientists, physicians, and policy-makers, with the identification of several research areas that emphasize the importance of prompt recognition and management of cases. At that meeting, there were laboratory scientists from epidemic and nonepidemic countries, including Finland, France, Germany, Russia, United Kingdom, Ukraine, United States (Centers for Disease Control and Prevention [CDC]), and WHO/EURO. These scientists are the founding members of ELWGD. Since then, ELWGD has enlarged and currently has participation from 20 different countries, with representation from Western and Eastern Europe, the United States, Australia, and Southeast Asia (table 1) .
The mission statement of ELWGD is "a collaborative and coordinated approach to the microbiology of diphtheria." The Downloaded from https://academic.oup.com/jid/article-abstract/181/Supplement_1/S146/838825 by guest on 06 April 2019 main objectives are to establish a network of collaborating laboratories not only in Europe but globally, to enhance collaboration between all participants, to establish a microbiologic surveillance of diphtheria in Europe, and to harmonize methodologies for laboratory diagnosis in epidemic areas and typing of the causative organism, leading to the establishment of a microbiologic surveillance system for all isolates of C. diphtheriae in the European Region and beyond [6, 7] .
Microbiologic Surveillance of Diphtheria in the European Region
An international microbiologic surveillance for all C. diphtheriae isolates from sporadic cases within the European Region was initiated in 1994 with collaboration from member countries of ELWGD and beyond (figure 1). Isolates of C. diphtheriae from outbreaks or suspected cases are usually referred to the Diphtheria Reference Center within the country (if available) or to a specialized laboratory that handles the causative organism. It is essential for each country to have the laboratory capacity to undertake all procedures for the microbiologic diagnosis of diphtheria.
To further complement the microbiologic surveillance, a standard method for molecular typing of C. diphtheriae isolates has been established, with ribotyping as the main tool [8] . Due to extensive collaborative typing studies among ELWGD, a database of ribotype patterns has been established at the Institut Pasteur (Paris), using their Taxotron software program for data analysis [9] . "Sub-databases" are now in place within centers in the United Kingdom, United States, and Finland. This database enables the provision of information on C. diphtheriae globally (i.e., the origin of outbreak strains and their relationship to endemic and epidemic strains worldwide). To date, 11000 isolates (both pre-epidemic and epidemic) from diphtheria patients, contacts, and carriers from various areas in Eastern Europe have been examined [9] . Isolates from imported cases have also been examined.
More than 70 different ribotypes have been identified globally and have provisionally been designated D1-D70 [10] . The predominating patterns within the European epidemic appear to be D1, D4, and D7. The ribotypes D1 and D4 are still disseminating, in view of the imported cases that have occurred in Western Europe [10] . The provisionally designated nomenclature, with "D" representing diphtheria, is currently used among the participating countries within ELWGD. From these studies, we have confirmed that geographic heterogeneity exists between strains from different regions and that database storage allows the recognition, confirmation, and identification of apparent clones worldwide [9, 11] .
Strengthening Diphtheria Laboratory Diagnostics
ELWGD plays a major role in the strengthening of laboratory diagnostics globally, particularly to those areas in greater need. The group provides advice to WHO and other agencies on laboratory diagnosis and the molecular epidemiology of C. diphtheriae. The major strengths of the group are its composition of scientific experts from internationally renowned organizations, which include the WHO Regional Office for Europe, the UK Public Health Laboratory Service (PHLS), the US CDC, Institut Pasteur, and national public health and microbiologic institutes from the European Region, Australia, and Southeast Asia.
In response to these diphtheria epidemics, a WHO manual on laboratory diagnosis has been produced that is complementary to the WHO manual on control and case management. These manuals have been translated and reproduced in the Russian language and have also been translated and adapted into the various national languages used within the Eastern European Region [12, 13] . Intercountry and national laboratory workshops and seminars on diphtheria diagnostics have been undertaken in all the NIS countries. These were modeled upon the laboratory training course developed by the PHLS/WHO Diphtheria Reference Laboratory. Laboratory workshops were first held in London in collaboration with the WHO Regional office for Europe to initially introduce key microbiologists from 12 of the 15 NIS countries to diphtheria diagnostic kits, to identify the key personnel in these areas, to identify problems within laboratory diagnostics for diphtheria, and, of most importance, to learn from each other.
The second WHO workshop was held in Lithuania for the Baltic States and was organized in collaboration with the PHLS and the National Public Health Institute in Helsinki. More than 40 workshops have now been held by key microbiologists in all 15 NIS countries for their own personnel. This project has been extremely successful and has contributed considerably to the improvements and standardization of laboratory diagnostics in all NIS countries.
As part of the WHO strategy to improve diphtheria surveillance and laboratory diagnostics, the WHO Regional Office for Europe in conjunction with the PHLS has also coordinated and supplied laboratory diagnostic kits for distribution to all NIS countries. This major project was initiated in November 1995 and has been in progress for 12 years. The task involved not only the preparation of all media supplies necessary for the laboratory investigation of diphtheria but also the ordering and packing of all support materials, such as swab packs, inoculation loops, microscope slides, pipettes, petri dishes, and even waterproof marker pens. All items were packed into specific kits appropriate for each stage of clinical diagnosis. Each kit contains sufficient materials to undertake the microbiologic examination of 100 cases and 1000 secondary cases or close contacts (table 2) .
Thus far, 70 kits have been dispatched because of the substantial financial aid from the international donor community in response to the appeal launched by WHO, UNICEF, and the International Federation of the Red Cross on 19 June 1995. The kits contain all media supplies and laboratory materials for the microbiologic diagnosis of diphtheria (table 2) . A special information booklet itemizing all the components and their use has been prepared and translated into Russian. This information is used in conjunction with the WHO manual on laboratory diagnosis [7, 13] . The recommended procedure for the laboratory diagnosis of diphtheria in epidemic areas is outlined in figure 2. These procedures are based upon the availability of diphtheria diagnostic kits within countries and are, therefore, very much "resource dependent."
International Quality Assurance Scheme for Laboratory Diagnosis of Diphtheria
To monitor the progress and any problems that may emerge with laboratory diagnostics, an External Quality Assurance (EQA) Program for laboratory diagnosis was initiated in 1995. Yearly distributions now extend to interested participants from laboratories that are not within ELWGD. Thus far, three distributions have been made: The first was on the evaluation of methodologies for toxigenicity testing (9 participating centers), the second on laboratory diagnostics (14 centers), and the third on diphtheria serologic assays (15 centers) [7, 14] . Overall, in the first distribution, there was a high standard of performance. Most laboratories used one test for detection of diphtheria toxin or a combination of two tests. The Elek test and polymerase chain reaction (PCR) were the most popular combinations: six of eight centers used the Elek test, two centers used PCR only, and two centers used the in vivo method as an additional test.
PCR is not recommended as a single test for toxigenicity because it indicates only the presence of the toxin gene; it is not an indicator of toxin expression. Some isolates have also been described that possess the toxin gene but are unable to express the protein; therefore, they are, for public health purposes, nontoxigenic [11] . The ideal tests for toxigenicity are the modified Elek test and newer methods, such as the enzyme immunoassay [11, 15, 16] . Since the first EQA distribution in 1995, laboratories within the European Region, the United States, Australia, and Vietnam have now reassessed their strategies and criteria for toxin testing.
The second EQA study consisted of 6 simulated throat specimens, which were distributed to 14 centers in Western Europe, Eastern Europe, the United States, and Australia. Most labDownloaded from https://academic.oup.com/jid/article-abstract/181/Supplement_1/S146/838825 by guest on 06 April 2019 oratories performed well; however, at that time, there was some variability in the methodology undertaken, which indicated the need for standardization of methods and reagents used for the laboratory diagnosis of diphtheria. Since 1996, these issues have been addressed by the publication of manuals, laboratory workshops and training, and the distribution of large consignments of laboratory kits to all countries within the NIS and to other countries upon request. Methods are now standardized among countries participating in ELWGD.
The yearly distribution of sample specimens for quality assurance is essential to maintain laboratory standards and control. The third distribution in 1997, consisted of simulated serum specimens for diphtheria serology. The results from this exercise strongly indicated the need for standardization of serologic procedures among countries [14] .
As part of the UK National EQA scheme, simulated samples were sent to 317 diagnostic laboratories within the United Kingdom: The sample was described as a throat swab from an overseas traveler returning from Kazakhstan with a sore throat. The specimen contained C. diphtheriae var. gravis (toxigenic), Streptococcus mitis, and Neisseria species. Only 30 laboratories (9%) performed toxigenicity tests. The remainder (81%) correctly identified the organism but did not perform toxigenicity tests; they all referred the isolate to the Reference Laboratory. The remainder (10%) were unable to identify the organism to species level [17] . This again highlights the importance of "reference center" facilities within countries.
WHO Strategies on Laboratory Networks
The establishment of a laboratory network within the European Region that provides timely, accurate and effective isolation, identification, and typing of C. diphtheriae for strengthening surveillance and control of diphtheria is crucial. The laboratory network should always provide information for programmatic action. The national laboratory should work in close collaboration with the immunization program of that country to confirm the diagnosis of diphtheria, monitor the carrier rates, identify geographic areas and populations at risk, focus vaccination efforts, and identify contacts. National laboratories along with their collaborating provincial or district laboratories should provide the foundation for diphtheria surveillance and control by the examination of specimens and the provision of timely and accurate results. Some National laboratories also provide laboratory support and expertise to neighboring countries that may lack facilities for diphtheria laboratory diagnostics. The laboratory has a crucial role in ensuring that the program for diphtheria control within a country fulfills its objectives.
Structure and Function of the Network
A three-level network of laboratories (i.e., national, regional, and specialized reference laboratories), each with defined responsibilities, should be considered as a basis for laboratory support to diphtheria control.
The National Laboratory provides services relating to the isolation and identification of C. diphtheriae, using standardized procedures, and would refer C. diphtheriae isolates to a specialized reference laboratory when appropriate and would also serve as the Diphtheria Reference Laboratory for that particular country.
The Regional Reference Laboratory would serve as a national laboratory for their country and also to other countries that do not have facilities. This laboratory would also undertake genotyping and other specialized procedures and serve as a training center in laboratory diagnostics and typing for other laboratory workers within the country and elsewhere.
Specialized reference laboratories are limited in number and function within the network. They prepare and distribute reference reagents, relevant standards, and training materials; distribute isolates and other materials for quality assurance exercises; definitively characterize C. diphtheriae isolates, using the latest standardized methodologies; maintain a "strain 
Conclusions
Predicting the future in the microbiology and epidemiology of diphtheria is difficult. Outbreaks among immunized populations show that diphtheria will return when immunity levels within a population decrease [2, 3] , as clearly illustrated in Eastern Europe. With the increase in international travel and the emergence of epidemic strains, the existence of diphtheria anywhere in the world represents a threat to unimmunized persons and those with low levels of immunity. These problems highlight the importance of strengthening epidemiologic surveillance and accessible and reliable laboratory screening. The situation for clinical and laboratory diagnosis has now been strengthened in some countries but needs to be strengthened in others, particularly in Western Europe, where a degree of complacency still exists. The international network (ELWGD) that has been formed clearly shows the importance of microbiologic collaboration so that countries can interact and react rapidly to a public health situation.
The situation currently seems to be improving in Eastern Europe, but new outbreaks are occurring in other countries [1, 11] . As the disease declines in incidence, accurate, sensitive, and specific laboratory confirmation of suspect cases becomes even more important and highlights even further the need to maintain and increase both clinical and laboratory awareness. This has been achieved for diphtheria in many countries through the successful collaboration of participants within ELWGD. ELWGD is a good model and successful example of coordinated international research leading directly to improved monitoring and containment of a resurgent infectious disease. The model could be used for laboratory-based surveillance of other vaccine-preventable diseases (e.g., pertussis, meningococcal meningitis, and Haemophilus influenzae infections), with the objective of accurate and reliable diagnosis and significant improvements in the control of infectious diseases worldwide.
